GLP-1–Based Therapy for Diabetes: What You Do Not Know Can Hurt You-Reference-Cited by-同舟云学术

GLP-1–Based Therapy for Diabetes: What You Do Not Know Can Hurt You

Published:2010-02-01 Issue:2 Volume:33 Page:453-455
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Butler Peter C.¹,Dry Sarah¹,Elashoff Robert¹

Affiliation:

1. From the Larry L. Hillblom Islet Research Center, Department of Pathology and Department of Biomathematics, University of California, Los Angeles, Los Angeles, California.

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/33/2/453/605737/zdc00210000453.pdf

Reference28 articles.

1. Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits;Drucker;Diabetes Care,2010

2. The incretin system and its role in type 2 diabetes mellitus;Holst;Mol Cell Endocrinol,2009

3. Therapeutic roles of peroxisome proliferator-activated receptor agonists;Staels;Diabetes,2005

4. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial;Dormandy;Lancet,2005

5. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial;Home;Lancet,2009

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity in Adolescents;New England Journal of Medicine;2023-10-05

2. GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes;Endocrinology and Diabetes;2022

3. Obesity in cystic fibrosis;Journal of Clinical & Translational Endocrinology;2021-12

4. Glucagon-Like Peptide 1 Receptor Agonist (GLP1RA) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies;Diabetes Therapy;2021-02-26

5. The Relationship Between Dipeptidyl Peptidase-4 Inhibitor Usage and Asymptomatic Amylase Lipase Increment in Type 2 Diabetes Mellitus Patients;Turkish Journal of Pharmaceutical Sciences;2020-02-01